Compare CPNG & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CPNG | ALC |
|---|---|---|
| Founded | 2010 | 1945 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Durable Goods | Ophthalmic Goods |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.5B | 32.4B |
| IPO Year | 2021 | 2002 |
| Metric | CPNG | ALC |
|---|---|---|
| Price | $16.65 | $66.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 12 |
| Target Price | $32.00 | ★ $89.38 |
| AVG Volume (30 Days) | ★ 20.1M | 2.6M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.25% |
| EPS Growth | ★ 37.50 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $34,534,000,000.00 | N/A |
| Revenue This Year | $13.15 | $7.99 |
| Revenue Next Year | $13.75 | $6.38 |
| P/E Ratio | ★ N/A | $38.31 |
| Revenue Growth | ★ 14.09 | N/A |
| 52 Week Low | $15.03 | $61.84 |
| 52 Week High | $34.08 | $92.55 |
| Indicator | CPNG | ALC |
|---|---|---|
| Relative Strength Index (RSI) | 44.10 | 41.93 |
| Support Level | $15.03 | $61.84 |
| Resistance Level | $20.75 | $81.92 |
| Average True Range (ATR) | 0.66 | 1.31 |
| MACD | 0.10 | 0.49 |
| Stochastic Oscillator | 88.24 | 71.56 |
Coupang is South Korea's largest e-commerce platform that sells both owned and third-party inventory. Headquartered in the US, Coupang operates e-commerce businesses mainly in South Korea and Taiwan. The company has built an integrated logistics network that covers the entirety of South Korea, with extensive fulfillment centers that ensure timely delivery, even for orders placed seconds before midnight. Outside of its bread-and-butter e-commerce business, Coupang has expanded into Rocket delivery services to third-party merchants (fulfillment and logistics by Coupang), online grocery delivery Rocket Fresh, online meal delivery (Eats), e-commerce in Taiwan, luxury e-commerce (Farfetch), and travel.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.